Clifford Chance (CC) and DLA Piper are among a raft of firms to have taken roles on Pfizer’s $11.9bn (£7.4bn) sale of its baby food business to Nestle, reports The Am Law Daily.
The purchase of the infant nutrition unit, which will give Nestle a bigger foothold in China and other emerging markets, has seen the Swiss food company turn to a Mayer Brown deal team led by M&A partners David Carpenter and John Boelter in New York and Chicago.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
